Results 31 to 40 of about 6,415,892 (312)

MOESM1 of White matter damage and systemic inflammation in Parkinsonâ s disease

open access: yes, 2017
Additional file 1: Supplementary methods of DTI data preprocessing and analysis.
Chiang, Pi-Ling   +7 more
openaire   +1 more source

How Cognition and Motivation “Freeze” the Motor Behavior in Parkinson’s Disease

open access: yesFrontiers in Neuroscience, 2019
ObjectiveFreezing of gait (FoG) is a debilitating problem in patients with PD. The multifactorial pathogenesis of FoG remains poorly understood. We aimed to find which factors are most strongly associated with the occurrence of FoG.MethodsThree hundred ...
Paola Ortelli   +9 more
doaj   +1 more source

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience

open access: yesFrontiers in Neuroscience, 2021
The international Linked Clinical Trials (iLCT) program for Parkinson’s to date represents one of the most comprehensive drug repurposing programs focused on one disease.
Simon R. W. Stott   +2 more
doaj   +1 more source

Additional file 1: of Cerebellar involvement in Parkinsonâ s disease resting tremor

open access: yes, 2016
Summary Analysis Data. (DOCX 13 kb)
Lefaivre, Shannon   +2 more
openaire   +1 more source

Additional file 3: of Meta-analysis of risk factors for Parkinsonâ s disease dementia

open access: yes, 2016
Details of factors not included in the meta-analysis. This file provided data of risk factors for Parkinsonâ s disease dementia that were mentioned in literature, but were not included in the meta-analysis due to limited number of studies or differences in study design. (DOCX 93 kb)
Yaqian Xu, Yang, Jing, Huifang Shang
openaire   +1 more source

MOESM2 of Brain mediators of systemic oxidative stress on perceptual impairments in Parkinsonâ s disease

open access: yes, 2015
Additional file 2: Table S1. Brain regions with gray matter volume reduction in the patients with Parkinsonâ s disease compared with the healthy control group.
Wei-Che Lin   +12 more
openaire   +1 more source

Additional file 1: of Ceruloplasmin functional changes in Parkinsonâ s disease-cerebrospinal fluid

open access: yes, 2015
Figure S1. Western blot analysis for contaminant hemoglobin detection. Figure S2. Immunoprecipitation of both resting- and oxidized-ceruloplasmin.Table S1. Spectrophotometric analysis for hemoglobin contaminant detection in CSF samples. (PDF 1445 kb)
Barbariga, Marco   +11 more
openaire   +1 more source

Does cueing training improve physical activity in patients with Parkinson's disease? [PDF]

open access: yes, 2010
Patients with Parkinson’s disease (PD) are encouraged to stay active to maintain their mobility. Ambulatory activity monitoring (AM) provides an objective way to determine type and amount of gait-related daily activities.
Nieuwboer, Alice   +17 more
core   +1 more source

Additional file 2: of Meta-analysis of risk factors for Parkinsonâ s disease dementia

open access: yes, 2016
Details of the study results. This file provided detailed results of meta-analysis of each risk factor. (DOCX 159 kb)
Xu, Yaqian, Yang, Jing, Shang, Huifang
openaire   +1 more source

PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches [PDF]

open access: yes, 2009
[18F]Fluoro-3,4-dihydroxyphenyl-l-alanine (FDOPA) was one of the first successful tracers for molecular imaging by positron emission tomography (PET), and has proven immensely valuable for studies of Parkinson’s disease.
Yoshitaka Kumakura   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy